142 related articles for article (PubMed ID: 29056973)
1. Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study.
Kastrup J; Schou M; Gustafsson I; Nielsen OW; Møgelvang R; Kofoed KF; Kragelund C; Hove JD; Fabricius-Bjerre A; Heitman M; Haack-Sørensen M; Lund LD; Johansen EM; Qayyum AA; Mathiasen AB; Ekblond A
Stem Cells Int; 2017; 2017():8506370. PubMed ID: 29056973
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE).
Paitazoglou C; Bergmann MW; Vrtovec B; Chamuleau SAJ; van Klarenbosch B; Wojakowski W; Michalewska-Włudarczyk A; Gyöngyösi M; Ekblond A; Haack-Sørensen M; Jaquet K; Vrangbaek K; Kastrup J;
Eur J Heart Fail; 2019 Aug; 21(8):1032-1041. PubMed ID: 30790396
[TBL] [Abstract][Full Text] [Related]
3. Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure.
Qayyum AA; Mouridsen M; Nilsson B; Gustafsson I; Schou M; Nielsen OW; Hove JD; Mathiasen AB; Jørgensen E; Helqvist S; Joshi FR; Johansen EM; Follin B; Juhl M; Højgaard LD; Haack-Sørensen M; Ekblond A; Kastrup J
ESC Heart Fail; 2023 Apr; 10(2):1170-1183. PubMed ID: 36638837
[TBL] [Abstract][Full Text] [Related]
4. Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety Study.
Kastrup J; Haack-Sørensen M; Juhl M; Harary Søndergaard R; Follin B; Drozd Lund L; Mønsted Johansen E; Ali Qayyum A; Bruun Mathiasen A; Jørgensen E; Helqvist S; Jørgen Elberg J; Bruunsgaard H; Ekblond A
Stem Cells Transl Med; 2017 Nov; 6(11):1963-1971. PubMed ID: 28880460
[TBL] [Abstract][Full Text] [Related]
5. Effect of allogeneic adipose tissue-derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction - the SCIENCE trial.
Qayyum AA; van Klarenbosch B; Frljak S; Cerar A; Poglajen G; Traxler-Weidenauer D; Nadrowski P; Paitazoglou C; Vrtovec B; Bergmann MW; Chamuleau SAJ; Wojakowski W; Gyöngyösi M; Kraaijeveld A; Hansen KS; Vrangbaek K; Jørgensen E; Helqvist S; Joshi FR; Johansen EM; Follin B; Juhl M; Højgaard LD; Mathiasen AB; Ekblond A; Haack-Sørensen M; Kastrup J;
Eur J Heart Fail; 2023 Apr; 25(4):576-587. PubMed ID: 36644821
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
[TBL] [Abstract][Full Text] [Related]
7. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
Chung ES; Miller L; Patel AN; Anderson RD; Mendelsohn FO; Traverse J; Silver KH; Shin J; Ewald G; Farr MJ; Anwaruddin S; Plat F; Fisher SJ; AuWerter AT; Pastore JM; Aras R; Penn MS
Eur Heart J; 2015 Sep; 36(33):2228-38. PubMed ID: 26056125
[TBL] [Abstract][Full Text] [Related]
8. Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter Double-Blind Controlled CAREMI Trial (Cardiac Stem Cells in Patients With Acute Myocardial Infarction).
Sanz-Ruiz R; Casado Plasencia A; Borlado LR; Fernández-Santos ME; Al-Daccak R; Claus P; Palacios I; Sádaba R; Charron D; Bogaert J; Mulet M; Yotti R; Gilaberte I; Bernad A; Bermejo J; Janssens S; Fernández-Avilés F
Circ Res; 2017 Jun; 121(1):71-80. PubMed ID: 28533209
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Magnetic Resonance Imaging used for Evaluation of Adipose-Derived Stromal Cell Therapy in Patients with Chronic Ischemic Heart Disease.
Qayyum AA; Mathiasen AB; Mygind ND; Vejlstrup NG; Kastrup J
Cell Transplant; 2019 Dec; 28(12):1700-1708. PubMed ID: 31698917
[TBL] [Abstract][Full Text] [Related]
10. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.
Díez-Tejedor E; Gutiérrez-Fernández M; Martínez-Sánchez P; Rodríguez-Frutos B; Ruiz-Ares G; Lara ML; Gimeno BF
J Stroke Cerebrovasc Dis; 2014; 23(10):2694-2700. PubMed ID: 25304723
[TBL] [Abstract][Full Text] [Related]
11. A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol.
van Rhijn-Brouwer FCC; Gremmels H; Fledderus JO; Schuurman AH; Bonte-Mineur F; Vonk MC; Voskuyl AE; de Vries-Bouwstra JK; Coert JH; Radstake TRDJ; van Laar JM; Verhaar MC;
BMJ Open; 2018 Aug; 8(8):e020479. PubMed ID: 30127049
[TBL] [Abstract][Full Text] [Related]
12. ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design.
Chakravarty T; Makkar RR; Ascheim DD; Traverse JH; Schatz R; DeMaria A; Francis GS; Povsic TJ; Smith RR; Lima JA; Pogoda JM; Marbán L; Henry TD
Cell Transplant; 2017 Feb; 26(2):205-214. PubMed ID: 27543900
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.
Fernández-Avilés F; Sanz-Ruiz R; Bogaert J; Casado Plasencia A; Gilaberte I; Belmans A; Fernández-Santos ME; Charron D; Mulet M; Yotti R; Palacios I; Luque M; Sádaba R; San Román JA; Larman M; Sánchez PL; Sanchís J; Jiménez MF; Claus P; Al-Daccak R; Lombardo E; Abad JL; DelaRosa O; Corcóstegui L; Bermejo J; Janssens S
Circ Res; 2018 Aug; 123(5):579-589. PubMed ID: 29921651
[TBL] [Abstract][Full Text] [Related]
14. Autologous adipose-derived stromal cell treatment for patients with refractory angina (MyStromalCell Trial): 3-years follow-up results.
Qayyum AA; Mathiasen AB; Helqvist S; Jørgensen E; Haack-Sørensen M; Ekblond A; Kastrup J
J Transl Med; 2019 Nov; 17(1):360. PubMed ID: 31711513
[TBL] [Abstract][Full Text] [Related]
15. The carvedilol hibernation reversible ischaemia trial, marker of success (CHRISTMAS) study. Methodology of a randomised, placebo controlled, multicentre study of carvedilol in hibernation and heart failure.
Pennell DJ; Ray SG; Davies G; Burgess M; Webster J; Slomka P; Atkinson P; Cleland JG
Int J Cardiol; 2000 Feb; 72(3):265-74. PubMed ID: 10716137
[TBL] [Abstract][Full Text] [Related]
16. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease.
Ripa RS
Dan Med J; 2012 Mar; 59(3):B4411. PubMed ID: 22381094
[TBL] [Abstract][Full Text] [Related]
18. Adipose-Derived Stromal Cells for Treatment of Patients with Chronic Ischemic Heart Disease (MyStromalCell Trial): A Randomized Placebo-Controlled Study.
Qayyum AA; Mathiasen AB; Mygind ND; Kühl JT; Jørgensen E; Helqvist S; Elberg JJ; Kofoed KF; Vejlstrup NG; Fischer-Nielsen A; Haack-Sørensen M; Ekblond A; Kastrup J
Stem Cells Int; 2017; 2017():5237063. PubMed ID: 29333165
[TBL] [Abstract][Full Text] [Related]
19. Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial.
Patel AN; Henry TD; Quyyumi AA; Schaer GL; Anderson RD; Toma C; East C; Remmers AE; Goodrich J; Desai AS; Recker D; DeMaria A;
Lancet; 2016 Jun; 387(10036):2412-21. PubMed ID: 27059887
[TBL] [Abstract][Full Text] [Related]
20. Design of a Phase 3 trial of intracoronary administration of human adenovirus 5 encoding human adenylyl cyclase type 6 (RT-100) gene transfer in patients with heart failure with reduced left ventricular ejection fraction: The FLOURISH Clinical Trial.
Penny WF; Henry TD; Watkins MW; Patel AN; Hammond HK
Am Heart J; 2018 Jul; 201():111-116. PubMed ID: 29763816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
